About Ganapati Biotech
Ganapati Biotech is a Healthcare company based in Delhi (India) founded in 2002. Wholesale trading of pharmaceutical and nephrology medicines in New Delhi. It operates on a B2B model. The company has 12 employees. Its Indian entity Ganapati Bio- Tech Limited reported revenue of ₹49.01 Cr. Ganapati Biotech offers products and services including Nephrology Medicines, Pharmaceutical Capsules, Pharmaceutical Tablets, Pharmaceutical Injections, and Soft Gelatin Capsules. Its focus areas include Pharmaceuticals, Medicines, Transplant and Nephrology. Similar companies include Entero Healthcare, Keimed and Sandor Medicaids; 3 of its 3 listed similar companies have raised funding.
Company details
Ganapati Biotech Limited operates as a wholesale trader and distributor of pharmaceutical products, including nephrology and transplant medicines. Based in New Delhi, India, the company supplies items like capsules, tablets, injections, and syrups to healthcare businesses. Established in 2002, it focuses on quality distribution with a team of 11 to 25 employees, serving the medical sector through B2B channels.
- Headquarters Delhi, India
- Employees 12
- SectorsHealthcare
- Phone•••• ••••
- Website ganapatibiotechltd.com
- Legal Name Ganapati Bio- Tech Limited
- Date of Incorporation 03 Feb, 1995
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹49.01 Cr
FY 2025 · +23% YoY
- Net Profit₹32.1 Lakh
FY 2025 · 1% margin
- EBITDA₹1.22 Cr
FY 2025 · 2% margin
- Employee Count12
Associated legal entities of Ganapati Biotech
Ganapati Biotech operates through Ganapati Bio- Tech Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ganapati Bio- Tech Limited CIN U74899DL1995PLC065017 | Active | 03 Feb 1995 | New Delhi, Delhi | ₹49.0 Cr | 12 | 4 | View details |
Products & Services of Ganapati Biotech
Ganapati Biotech offers a comprehensive portfolio of products and services, including Nephrology Medicines, Pharmaceutical Capsules, Pharmaceutical Tablets, Pharmaceutical Injections, and Soft Gelatin Capsules.
Treatments for kidney-related diseases and conditions
Capsules for various health and medical applications
Tablets used in general pharmaceutical treatments
Injections for targeted medical therapies
Gelatin capsules for easy consumption of medicines
Treatments related to viral infections and diseases
Liquid formulations for oral medication intake
Medications specifically for kidney disorders
Board of directors of Ganapati Bio- Tech Limited (Ganapati Biotech)
Ganapati Bio- Tech Limited is the primary company behind Ganapati Biotech. The board of Ganapati Bio- Tech Limited currently have 4 directors; the longest-serving is Manoj Kumar Goel, appointed in 2002. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Manoj Kumar Goel DIN 00322866 | Whole-time director | 20 May 2002 | 24 yrs 5 mo | Ganapati Bio- Tech Limited |
| Rameshwar Dayal Goel DIN 02161706 | Whole-time director | 01 May 2008 | 18 yrs 5 mo | Ganapati Bio- Tech Limited |
| Sunita Goel DIN 07130238 | Director | 19 Mar 2015 | 11 yrs 7 mo | Ganapati Bio- Tech Limited |
| Hardik Goel DIN 07822955 | Director | 16 May 2017 | 9 yrs 5 mo | Ganapati Bio- Tech Limited |
Financials of Ganapati Biotech
Figures of Ganapati Bio- Tech Limited, the primary company behind Ganapati Biotech, for FY 2025. Revenue was ₹49.01 Cr (+23% year on year). Net profit was ₹32.1 Lakh (1% margin). EBITDA was ₹1.22 Cr (2% margin). Revenue has grown at a compounded annual rate of +13% over three years and +9% over five years.
- ₹49.01 CrRevenue · FY 2025 · +23% YoY
- ₹32.1 LakhNet profit · 1% margin
- ₹1.22 CrEBITDA · 2% margin
- ₹6.9 LakhPaid-up capital
- 12Employees (provident fund records)
- +13%Revenue CAGR, 3 years
- +9%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Ganapati Bio- Tech Limited are on its company page.
Detailed financial statements for Ganapati Biotech
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Ganapati Biotech
Ganapati Biotech has 3 listed similar companies in our database, 3 of them funded. They include Entero Healthcare, Keimed and Sandor Medicaids.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| enterohealthcare.com | 2018 | Mumbai, India | $59.67M | 817 | India's leading healthcare products distribution platform | |
| keimed.com | 2000 | Hyderabad, India | $16.62M | 588 | Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. | |
| sandor.co.in | 1995 | Hyderabad, India | $8.98M | 161 | Provider of medical equipment, devices, and drugs distribution services |
Detailed similar companies of Ganapati Biotech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Ganapati Biotech
Ganapati Biotech was founded in 2002.
Ganapati Biotech is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Ganapati Biotech has 12 employees.
The primary company behind Ganapati Biotech, Ganapati Bio- Tech Limited, reported revenue of ₹49.01 Cr for FY 2025, up 23% year on year.
Ganapati Biotech Limited operates as a wholesale trader and distributor of pharmaceutical products, including nephrology and transplant medicines. Based in New Delhi, India, the company supplies items like capsules, tablets, injections, and syrups to healthcare businesses. Established in 2002, it focuses on quality distribution with a team of 11 to 25 employees, serving the medical sector through B2B channels.
Ganapati Biotech's top competitors include Entero Healthcare, Keimed and Sandor Medicaids.
Ganapati Biotech offers Nephrology Medicines, Pharmaceutical Capsules, Pharmaceutical Tablets, Pharmaceutical Injections, and 4 more products and services.
Ganapati Biotech operates through Ganapati Bio- Tech Limited.
The legal entities of Ganapati Biotech currently have 4 directors, including Hardik Goel, Rameshwar Dayal Goel, Sunita Goel and others.